Milestone validates the clinical potential of BSI-082 as a synergistic combination partner for antibody-drug conjugates ...
AdvanCell and 48Hour Discovery Announce Collaboration and Exclusive Licensing Agreement to Develop a Lead-212 Alpha ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results